| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 69.58B | 76.72B | 68.47B | 63.73B | 56.98B | 52.21B |
| Gross Profit | 36.46B | 37.77B | 36.17B | 33.72B | 29.10B | 28.05B |
| EBITDA | 30.75B | 34.77B | 30.53B | 27.54B | 24.37B | 24.61B |
| Net Income | 24.05B | 26.39B | 23.80B | 22.19B | 18.06B | 18.89B |
Balance Sheet | ||||||
| Total Assets | 87.03B | 99.34B | 101.35B | 99.36B | 92.76B | 87.35B |
| Cash, Cash Equivalents and Short-Term Investments | 42.75B | 55.10B | 63.11B | 54.45B | 54.66B | 50.13B |
| Total Debt | 369.00M | 325.00M | 456.00M | 429.61M | 694.02M | 833.85M |
| Total Liabilities | 19.50B | 21.07B | 17.73B | 20.77B | 18.17B | 16.35B |
| Stockholders Equity | 67.52B | 78.27B | 83.62B | 78.59B | 74.59B | 71.00B |
Cash Flow | ||||||
| Free Cash Flow | 20.15B | 28.34B | 21.64B | 17.61B | 17.20B | 18.19B |
| Operating Cash Flow | 20.59B | 28.86B | 21.99B | 17.91B | 17.58B | 18.56B |
| Investing Cash Flow | -11.17B | 6.89B | -24.53B | 15.98B | 1.37B | -1.67B |
| Financing Cash Flow | -23.20B | -34.49B | -20.96B | -19.58B | -16.65B | -17.33B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | ₹843.58B | 17.40 | ― | 5.05% | 12.05% | 10.67% | |
67 Neutral | ₹1.28T | 21.36 | ― | 1.08% | 11.31% | 9.00% | |
64 Neutral | ₹21.43B | 29.12 | ― | 1.34% | 8.19% | -1.00% | |
63 Neutral | ₹430.12B | 24.00 | ― | 0.88% | 33.81% | 89.36% | |
62 Neutral | ₹109.53B | 118.88 | ― | 0.69% | 22.17% | 32.02% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ₹3.61B | 40.24 | ― | ― | -4.24% | ― |